Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Reyes Sancho Tello"'
1
Akademický článek
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes
Autor: Juan Carlos Caballero, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Jesús María Hernández Sánchez, Helena Pomares, Mercedes Sánchez Barba, María Abáigar, Bernardo González, Brayan Merchán, Reyes Sancho-Tello, Marta Callejas, Carolina Muñoz-Novas, Carlos Cerveró, Guillermo Sanz, Jesús María Hernández Rivas, María Díez Campelo;
Publikováno v: Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Erythropoiesis stimulating agents (ESAs) are the first-line therapy in patients with lower-risk myelodysplastic syndromes (LR-MDS). Some predictive factors for ESAs response have been identified. Type and number of somatic mutations have
Externí odkaz: https://doaj.org/article/aae5bf162b0d4831a1ded6c9dd145238
Zobrazit plný text záznamu
2
Akademický článek
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Autor: Esperanza Such, José Cervera, Dolors Costa, Francesc Solé, Teresa Vallespí, Elisa Luño, Rosa Collado, María J. Calasanz, Jesús M. Hernández-Rivas, Juan C. Cigudosa, Benet Nomdedeu, Mar Mallo, Felix Carbonell, Javier Bueno, María T. Ardanaz, Fernando Ramos, Mar Tormo, Reyes Sancho-Tello, Consuelo del Cañizo, Valle Gómez, Victor Marco, Blanca Xicoy, Santiago Bonanad, Carmen Pedro, Teresa Bernal, Guillermo F. Sanz
Publikováno v: Haematologica, Vol 96, Iss 3 (2011)
Background The prognostic value of cytogenetic findings in chronic myelomonocytic leukemia is unclear. Our purpose was to evaluate the independent prognostic impact of cytogenetic abnormalities in a large series of patients with chronic myelomonocyti
Externí odkaz: https://doaj.org/article/aeb16864d3c2414aa60ca4fb5ab986f7
Zobrazit plný text záznamu
4
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Autor: Mario Cazzola, Anna Gallì, José Cervera, Torsten Haferlach, Reyes Sancho-Tello, Luca Malcovati, Ettore Rizzo, Ilaria Ambaglio, Silvia Catricalà, Ana Vicente, Chiara Elena, Manja Meggendorfer, Annette Fasan, Silvia Zibellini, Guillermo Sanz, Esther Schuler, María López-Pavía, Andrea Kuendgen, Elisabetta Molteni, Claudia Haferlach, Ulrich Germing, Esperanza Such, Erica Travaglino
Publikováno v: BLOOD
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm with variable clinical course. To predict the clinical outcome, we previously developed a CMML-specific prognostic scoring system (CPSS) based on clinical paramet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4634b1990a30a3c00921954809ef5859
https://doi.org/10.1182/blood-2016-05-714030
Zobrazit plný text záznamu
5
Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload
Autor: David Ivars, Rosa Collado, Mar Tormo, Pedro Pérez, Magdalena Sanchez, Jose Luis Garcia-Gimenez, Nuria Yagüe, Mercedes Egea, Carmen Alguero, M. Carmen Tormos, Guillermo T. Sáez, Felix Carbonell, Beatriz Arrizabalaga, Mayte Orero, Ana I. Regadera, J. Enrique O'Connor, Laura Diaz, Elena Vidal, M. Angeles Ruiz, Reyes Sancho-Tello
Publikováno v: BLOOD
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Abstract 4956 Introduction. Patients with Myelodysplastic Syndrome (MDS) are susceptible to developing iron overload as a response to the red blood cell (RBC) transfusions and ineffective hematopoiesis. This iron overload (IOL) is characterized by an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aabd1dd5cba9bd491015ad00838da64
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9718
Zobrazit plný text záznamu
6
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Autor: Benet Nomdedeu, José Cervera, Santiago Bonanad, Rosa Collado, Valle Gomez, Teresa Vallespi, Fernando Ramos, Guillermo Sanz, Esperanza Such, Javier Bueno, Francesc Solé, Teresa Bernal, Mar Mallo, Dolors Costa, Victor Marco, Juan C. Cigudosa, Elisa Luño, María Teresa Ardanaz, Carmen Pedro, Jesús M. Hernández-Rivas, Reyes Sancho-Tello, María José Calasanz, Felix Carbonell, Consuelo del Cañizo, Mar Tormo, Blanca Xicoy
Publikováno v: WOS
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
This study was supported in part by research funding from the “Instituto de Salud Carlos III” grants RD06/0020/0031, RD07/0020/2004, CA08/00141 and grants from DIUE, Generalitat de Catalunya (2009SGR541)
Such, E., Cervera, J., Costa, D., Sol
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16a572bdd2e79b19dc146411bfe4a80
http://hdl.handle.net/10651/24014
Zobrazit plný text záznamu
7
A Score Based on IPSS-R, Ferritin and EPO Levels Predicts Erythroid Response to ESAs and Survival in Lower Risk Anemic MDS Patients with High Probability of Response to ESAs: Spresas Sub-Analysis from the GESMD
Autor: Jose F Falantes, Asuncion Mora Casado, María López-Pavía, Guillermo Sanz, Sanchez Barba Mercedes, Marisa Calabuig, J. Muñoz, Helena Pomares, Brayan Merchan, Reyes Sancho Tello, M.J. Arcos, María Consuelo del Cañizo, Marta Callejas, Bernardo Gonzalez, Maria Diez Campelo, Esperanza Such, Luis Benlloch, Luz Amigo, Fernando Ramos, Elisa Luño, Abelardo Bárez, M. Gómez, María Teresa Cedena, Montse Cortes Sansa, María J. Arilla, María-José Jiménez, Andrea Campeny, Ana Vicente, Raquel de Paz, Julio Dávila, Andrés Insunza, Carlos Fernandez Lago, Carmen Pedro, Edgardo Barranco, Maria Dolores Linares Latorre, Angeles Medina, Patricia Font, Jose Antonio Gonzalez Hurtado, Maria Vahi, Valle Gomez, Carolina Muñoz, J. Casaño, Maria José Requena, María Pedreño, Raquel del Campo, Regina Garcia, Carlos Cerveró, Teresa Bernal
Publikováno v: Blood. 126:2896-2896
INTRODUCTION Anemia is the most frequent cytopenia in lower-risk MDS. Erythropoietic-stimulating agents (ESAs) are commonly used in these patients. The use of ÒclassicalÓ parameters (EPO and ferritin levels) and the revised IPSS (IPSS-R) has been p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d2ed7090ca934931c5965ab104a9f7e
https://doi.org/10.1182/blood.v126.23.2896.2896
Zobrazit plný text záznamu
9
Effectiveness and Tolerance of Azacitidine for Treating Patients with Chronic Myelomonocytic Leukemia in Community-Based Management
Autor: Marta Laguna García, Angela Ibañez, Maria E Amutio, Guillermo Sanz, Regina Garcia, Jose F Falantes, Alicia Bailen, Manuel Almagro, Reyes Sancho-Tello
Publikováno v: Blood. 114:4855-4855
Abstract 4855 Introduction Azacitidine (AZA) was recently approved in Europe by the EMEA for the treatment of Chronic Myelomonocytic Leukemia (CMMoL). Traditionally, CMMoL has been considered as part of the myelodysplastic syndrome (MDS) according to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::461b894c1d7638e817c165b75fb94165
https://doi.org/10.1182/blood.v114.22.4855.4855
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje